Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells.
about
Both PD-1 ligands protect the kidney from ischemia reperfusion injury.Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactionsA novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.Organ-specific differences in achieving toleranceAirway epithelial cells suppress T cell proliferation by an IFNγ/STAT1/TGFβ-dependent mechanism.Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma.Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.Tissue expression of PD-L1 mediates peripheral T cell tolerance.Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cellsThe PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus.End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.Loss of B7-H1 expression by recipient parenchymal cells leads to expansion of infiltrating donor CD8+ T cells and persistence of graft-versus-host disease.Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation.Heart transplantation: challenges facing the field.FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance.Tubulointerstitial nephritis as adverse effect of programmed cell death 1 inhibitor, nivolumab, showed distinct histological findings.Anti-CD3 mAb treatment cures PDL1-/-.NOD mice of diabetes but precipitates fatal myocarditis.Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
P2860
Q30301290-0E493C95-D10B-430B-BF04-3C13A070767BQ33627023-3305E34D-707E-4A61-A014-0EA734825592Q33822472-B5A97C03-FA91-4DFF-9D25-F9CC98493967Q34582934-2F2A6778-6C76-4F62-A9A7-D07A2DD3E09BQ35911564-0440D074-A1C6-4EAA-939D-D751FC5111D5Q35950180-E1B32A59-226C-4583-8FE8-C576D091B9F4Q36047265-3920D897-60EB-47FF-9163-F4B5EDFAB61CQ36198449-812704BE-2F1B-4541-A00C-3528CA7E7638Q36228541-4745683C-F347-47BA-900D-D0F9A98FB729Q36667235-FFC0F509-DD0E-44A4-95D7-A94A6F7D1178Q37276576-9E03029D-8D56-4D81-93BE-B7667D0E67A9Q37307349-AAEB8BAF-114F-4555-BF54-FC4446602B59Q37348924-2A4FE2D0-DDAD-4F38-A6C4-A1EDCB2474BEQ37393099-EF97617C-344C-40B7-8629-97B450FE061FQ37408390-5FCC49C1-9CF9-4472-970A-DE9CCE277B91Q37478912-ED4D3C14-9C29-43FE-A8D6-8EED9A635CA0Q37479232-F364F4FF-2308-40F7-BA71-E5CBE928327DQ37501812-50A57C95-34E5-4748-BBC9-BFB556583134Q37577538-5BB8C6F0-BA36-46A5-8BB4-D21F081EA279Q37717939-2479A7F4-5228-4AC4-B342-67997804DECFQ39066197-8DDAAC10-10FB-4114-ABEE-DF903BCE3CE7Q40076388-3585D264-F666-4AEA-BAB0-585FE1B9C9B2Q42103691-8BC60AB7-8239-4181-B494-E3E4F8E89CA9Q48081296-C26AAAF1-D3BA-4C56-A26C-6DC7A81FB13BQ52682746-253131EF-174D-4D94-A33B-E4DD0476F247
P2860
Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Suppressed T-cell activation b ...... enal tubular epithelial cells.
@en
Suppressed T-cell activation b ...... enal tubular epithelial cells.
@nl
type
label
Suppressed T-cell activation b ...... enal tubular epithelial cells.
@en
Suppressed T-cell activation b ...... enal tubular epithelial cells.
@nl
prefLabel
Suppressed T-cell activation b ...... enal tubular epithelial cells.
@en
Suppressed T-cell activation b ...... enal tubular epithelial cells.
@nl
P2093
P356
P1476
Suppressed T-cell activation b ...... enal tubular epithelial cells.
@en
P2093
Michel Le Hir
Minghui Wang
Patricia Wahl
Roland Schoop
Rudolf P Wüthrich
Uwe Heemann
P304
P356
10.1093/NDT/GFH423
P407
P577
2004-09-07T00:00:00Z